ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

China's Sinovac starts production of COVID-19 vaccine candidate

Compatriot CanSino also rushes for mass output as clinical trials continue

Students in Indonesia wear protective face masks. Sinovac has agreed to supply 40 million doses to an Indonesian state-owned company.   © Reuters

DALIAN, China -- Sinovac Biotech has begun manufacturing a coronavirus vaccine candidate on a pilot basis, as China shifts toward the mass production stage in the global immunization race.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more